R05CB06 • ambroxol • Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics
Ambroxol is a mucolytic agent used to treat respiratory conditions characterized by excessive production of viscous mucus. It is indicated for acute and chronic bronchitis, asthma, chronic obstructive pulmonary disease (COPD), and other lung conditions involving difficulty in mucus clearance.
Ambroxol works by reducing mucus viscosity and stimulating the activity of cilia in the airways, facilitating expectoration. It is effective in relieving productive cough and improving breathing.
Additionally, ambroxol has anti-inflammatory and antioxidant properties, making it useful in reducing airway inflammation. In some cases, it is also used to alleviate sore throat pain due to its local anesthetic effect.
It is available in the form of tablets, syrup, oral solution, or inhalation, and is well-tolerated by most patients. Side effects are rare and may include nausea, stomach discomfort, or mild allergic reactions.
Substance: ambroxol
Date of last drug list: 01-01-2016
Commercial code: W62108002
Concentration: 30mg
Pharmaceutical form: effervescent tablets
Quantity: 20
Product type: generic
Prescription restrictions: OTC - Over the Counter = medicines that do not require a prescription.
Manufacturer: HERMES ARZNEIMITTEL GMBH - GERMANIA
Holder: ACTAVIS GROUP PTC EHF. - ISLANDA
Number: 8120/2015/02
Shelf life: 3 years